Journal of Investigative and Clinical Dentistry
© John Wiley & Sons Australia, Ltd
Edited By: Professor Lakshman Samaranayake, University of Queensland, Editor-in-Chief
Online ISSN: 2041-1626
SUBMISSION OF MANUSCRIPTS
Thank you for your interest in Journal of Investigative and Clinical Dentistry. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://.mc.manuscriptcentral.com/jicd
If you need to contact the Editorial Office directly, please email email@example.com
We are looking forward to your submission.
EDITORIAL AND CONTENT CONSIDERATIONS
Aims and Scope
Journal of Investigative and Clinical Dentistry (JICD) aims to publish quality, peer reviewed original research and topical reviews on all aspects of investigative and clinical dentistry and craniofacial research, including molecular studies related to oral health and disease. Although international in outlook, the Editors especially encourage papers from the Asia Pacific. The journal also aims to provide clinicians, scientists and students of dentistry with a knowledge transfer platform for rapid publication of reports through an international journal, which will be available free online until 2012.
Its scope, therefore, is broad, inclusive and international, but with a particular focus on Asia Pacific. The journal accepts the following types of manuscripts: laboratory investigations, clinical investigations, full reviews and mini reviews. The Editors welcome manuscripts in the following key thematic areas in oral and maxillofacial sciences:
• Community Dentistry and Oral Epidemiology
• Conservative Dentistry
• Dental Biomaterials
• Dental Pedagogy
• Endodontics and Traumatology
• Implant Dentistry
• Oral Biosciences
• Oral and Maxillofacial Surgery
• Oral Medicine
• Oral Microbiology
• Oral Pathology
• Oral Radiology
• Oral Rehabilitation
• Periodontology and Periodontal Medicine
Editorial Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Manuscripts should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader.
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken.
Human Studies. Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).
Clinical Trials. Clinical trials should be reported using the CONSORT guidelines available at www.consort-statement.org A CONSORT checklist should also be included in the submission material.
The journal encourages authors submitting manuscripts reporting from a clinical trial to register the trials in any of the following free, public clinical trials registries: www.clinicaltrials.gov, http://clinicaltrials-dev.ifpma.org, http://isrctn.org. The clinical trial registration number and name of the trial register will then be published with the paper.
Use of Animals in Research. Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
Conflict of Interest. Authors are required to disclose all sources of institutional, private and corporate financial support for their study. Suppliers of materials (for free or at a discount from current rates) should be named in the source of funding and their location (town, state/county, country) included. Other suppliers will be identified in the text. If no funding has been available other than that of the author's institution, this should be specified upon submission. Authors are also required to disclose any potential conflict of interest. These include financial interests (for example patent, ownership, stock ownership, consultancies, speaker's fee,) or provision of study materials by their manufacturer for free or at a discount from current rates. Author's conflict of interest (or information specifying the absence of conflicts of interest) and the sources of funding for the research will be published under a separate heading entitled “Conflict of Interest and Sources of Funding Statement”. See www.icmje.org/#conflicts for generally accepted definitions.
Authorship and Acknowledgements. The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and i) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.
Reproduction of Copyright Material. If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html
Plagiarism Detection. The journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
Committee on Publication Ethics. The journal is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE).
The following categories of papers are accepted by JICD.
Please note that Case Reports are no longer accepted.
(i) Original papers,
(ii) Review articles (full reviews and mini reviews),
(iii) Short communications,
Please see below for the submission details of each category of paper and note carefully the instructions.
Word limit: 4,000 words maximum including abstract and references
Abstract: 200 words maximum and must include subheadings
References: In general, less than 30.
Figures/Tables: Total of no more than 6 figures and tables.
Description: Full-length reports of current research in either basic or clinical science. (Narrative type reviews are not encouraged and meta-analyses and Cochrane type reviews are desirable) .
Full reviews. It is desirable that authors first electronically submit an outline of their proposed article for evaluation by the Editor-in-Chief (firstname.lastname@example.org). The outline should be no more than two, double-spaced pages in size 12 font, in which the authors describe in bullet point format the objectives and contents of the report. Once the proposal has been evaluated, the authors will be informed of the results of the Editor’s initial consideration of their proposal. Reviews should NOT take on the IMRAD style, but must contain an abstract, introduction, the review proper, the conclusions and references.Authors must indicate the word length at the beginning of their article.
Full Review Articles
Word limit: 5,000 words maximum including abstract
Abstract: 200 words maximum, unstructured
References: no limit
Figures/Tables: Total of no more than 7 figures (15 images in total)
Minireviews. Minireviews are expected to be focused discussions of defined topics. A topical outline should be provided to the Editor-in-Chief for approval prior to submission of the completed minireview manuscript in Rapid Review.Minireviews are not expected to be comprehensive reviews of the literature but rather focused discussions of specific topics.
Word limit: 4,000 words maximum including abstract
Abstract: 100 words maximum, unstructured
References: no more than 30
Figures/Tables: Total of no more than 3 figures/tables.
Letter to the Editor
Word limit: 800 words maximum
Abstract: not required
References: 5 maximum
Figures/Tables: 1 maximum
Description:Letters to the Editor are intended to provide an opportunity to discuss issues related to previously published original articles, case reports or short communications and should not be used for the presentation of the authors’ preliminary data from their own investigations.
Word limit: 3,000 words
maximum including abstract
Abstract: 100 words maximum, unstructured
References: no more than 30
Figures/Tables: Total of no more than 3 figures/tables.
These manuscripts are to provide an opportunity for the presentation of preliminary or brief observations that do not warrant a full paper. The manuscript should be prepared in the same format as an Original Article.
Please note that Case Reports are no longer accepted by the Journal.
PREPARATION OF THE MANUSCRIPT
Pre-acceptance English-language editing
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. Visit our site to learn about the options. All services are paid for and arranged by the author. Please note using the Wiley English Language Editing Service does not guarantee that your paper will be accepted by this journal.
Optimising Your Article for Search Engines
Many students and researchers looking for information online will use search engines such as Google, Yahoo or similar. By optimising your article for search engines, you will increase the chance of someone finding it. This in turn will make it more likely to be viewed and/or cited in another work. We have compiled these guidelines to enable you to maximise the web-friendliness of the most public part of your article.
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org
Spelling. The Journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary.
Units. All measurements must be given in SI or SI-derived units.
Abbreviations. Abbreviations should be used sparingly – only where they ease the reader's task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Genetic nomenclature. Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Parts of the manuscript
The manuscript should be submitted in separate files: title page, main text file, figures.
The title page should contain:
(i) the title of the paper. This should be short, informative and contain the major key words. Do not use abbreviations in the title.
(ii) the full names of the authors and
(iii) the addresses of the institutions at which the work was carried out
(iv) the full postal and email address, plus telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
(v) A short running title (less than 40 characters) should also be provided.
Main text file
The main text file should be presented in the following order:
(i) Abstract and key words,
(ii) Text consisting of Introduction, Material and Methods, Results and Discussion,
(iii) Conflict of Interest and Sources of Funding Statement,
(vii) Tables (each table complete with title and footnotes).
(viii) Figure legends.
Figures should be supplied as separate files. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Abstract and key words
All articles must have an abstract that states in 200 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. For Original Articles, divide the abstract with the headings: Aim, Methods, Results, Conclusions. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion (IMRAD style).
Conflict of Interest and Sources of Funding Statement
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors' industrial links and affiliations. For more detail on the Conflict of Interest and Sources of Funding Statement please refer to the section on Ethical Considerations.
The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated in the style used in Index Medicus.
Authors are responsible for the accuracy of the references.
1 Botticelli D, Berglundh T, Lindhe J. Hard-tissue alterations following immediate implant placement in extraction sites. J Clin Periodontol 2004; 10: 820–8.
2 Taubman MA, Ebersole JL, Smith DJ. Association between systemic and local antibody and periodontal diseases. In: Genco RJ, Mergenhagen SE, ed. Host-parasite interactions in periodontal diseases. Washington, DC: Am Soc Microbiol, 1982: 283–98.
Cancer-Pain.org [homepage on the Internet]. Association of Cancer Online Resources, New York c2000-01 [updated 16 May 2002; cited 9 Jul 2002]. Available from: http://www.cancer-pain.org/
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Do not include reference citations in tables and table legends.
Figure legends. Type figure legends on a separate page. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Do not include reference citations in figures and figure legends.
All illustrations (line drawings and photographs) are classified as figures. Figures should be numbered using Arabic numerals, and cited in consecutive order in the text. Figures should be sized to fit within the column (83 mm), intermediate (125 mm) or the full text width (171 mm). Each figure should be supplied as a separate file, with the figure number incorporated in the file name.
Preparation of Electronic Figures for Publication: Although low quality images are adequate for review purposes, print publication requires high quality images to prevent the final product being blurred or fuzzy. Submit EPS (line art) or TIFF (halftone/photographs) files only. MS PowerPoint and Word Graphics are unsuitable for printed pictures. Do not use pixel-oriented programmes. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible). For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: line art: >600 dpi; half-tones (including gel photographs): >300 dpi; figures containing both halftone and line images: >600 dpi.
More advice on figures can be found at Wiley’s guidelines for preparation of figures: http://authorservices.wiley.com/bauthor/illustration.asp
A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file. The cover letter must also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author's contribution to the paper is to be quantified.
Two Word-files need to be included upon submission: A title page file and a main text file that includes all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.
The main text file should be prepared using Microsoft Word, using 1.5 line spacing. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.
Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files will be required.
Associate your ScholarOne account with your ORCID iD
ORCID iD is a unique and persistent identifier that distinguishes you from every other researcher and connects you and your research activities. We encourage you to register for an ORCID iD and then associate it with your ScholarOne account. Click here to find out how.
PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. More details on the copyright and licencing options for the journal appear below.
Wiley’s Author Services
Author Services enables authors to track their article through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://www.authorservices.wiley.com/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Once the paper has been typeset the corresponding author will receive an e-mail alert containing instructions on how to provide proof corrections to the article. It is therefore essential that a working e-mail address is provided for the corresponding author.
The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.
A PDF reprint of the article will be supplied free of charge to the corresponding author. Additional printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com/cos. If you have queries about offprints please e-mail: email@example.com.
Author Marketing Toolkit
The Wiley Author Marketing Toolkit provide authors with support on how to use social media, publicity, conferences, multimedia, email and the web to promote their article.
COPYRIGHT, LICENSING AND ONLINE OPEN
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.
Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.
Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.
OnlineOpen – Wiley’s Open Access Option: OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.
Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specifically about Self-Archiving definitions and policies.
Guidelines updated 3 June 2015